The Holbrook's Journey with IBD
When Melissa’s son Mason, 13, started showing signs of Crohn’s as an infant, the experience felt eerily familiar, and she and her husband braced themselves for a long diagnostic journey. By the time her daughter Piper, 12, began showing symptoms at 10, Melissa had already learned how to advocate fiercely for proper care. She pushed for an emergency colonoscopy and secured a diagnosis for her daughter in just two weeks, a stark contrast from what many families experience.
Still, the process was far from easy. Melissa recalls feeling dismissed at times, as her concerns were often attributed to common assumptions, like stomach aches being linked to anxiety or typical childhood bowel habits, rather than prompting a deeper look into conditions such as Crohn’s or colitis.
Despite it all, Melissa feels that her family’s journey with Crohn’s has been “the biggest blessing” in their lives. They understand how fast one’s health can change, and they’ve learned to appreciate the good days and take nothing for granted.
The Challenge of Finding the Right Treatment
Treatment decisions add another layer of complexity for children. Many medications approved for adults have not yet been proven safe or effective for pediatric patients.
Melissa has also found that it’s not easy to pivot, and you can’t go back to many types of medication if they’ve been tried before. Treatment changes take time, planning, and come with their own set of logistical hurdles, which can lead to more pain and uncertainty. She’s realized that navigating so many difficult choices brings a sense of decision fatigue as a caregiver.
Precision Medicine Brings Hope
The potential of precision medicine feels both practical and game-changing for Melissa. Instead of a trial‑and‑error approach, precision medicine could use a patient’s biology, including genetic markers, to guide treatment decisions. It aims to provide targeted and personalized treatment to every patient.
“Care should already be personalized,” she says. “Every patient is different, even within my own family, and how they respond to treatment varies dramatically.”
She believes precision medicine could have changed her family’s journey, reducing the time spent coordinating care, the time spent waiting for results, and the time spent trying to find the best treatments. More importantly, she sees it as a path towards helping patients reach remission faster.
Investment Matters Now
One IBD clinic, or one hospital alone, she believes, cannot solve the systemic challenges facing Crohn’s and colitis care. However, organizations like Crohn’s and Colitis Canada play a crucial role in driving research and collaboration nationally, advocating for patients, and pushing for innovation.
“Precision medicine is the right path forward,” she says. “It brings hope that families like mine will spend less time navigating the complexities of Crohn’s and colitis and more time living their lives.”
“Now’s the time.”